A 2011 paper in the Journal of Clinical Investigation whose PubPeer entry we highlighted in September has been retracted.
Here’s the notice for “Denitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patients,” a 2011 paper by researchers at Johns Hopkins and Imperial College: Continue reading COPD paper in JCI retracted following PubPeer critiques
In July, a PubPeer commenter called out a paper in Biochimica et Biophysica Acta for image duplication; by September, the paper was retracted for the exact reason detailed in the anonymous comment.
Here’s the notice for “Effect of ST3GAL 4 and FUT 7 on sialyl Lewis X synthesis and multidrug resistance in human acute myeloid leukemia,” a paper initially published in June: Continue reading PubPeer strikes again: Leukemia paper retracted for image duplications
In June, we reported on a retraction in Current Biology that came after a number of PubPeer commenters suggested that the authors had engaged in figure manipulation, memorably comparing watching the published videos to playing the old-school arcade game “Space Invaders.”
Now a second paper from the same team has been retracted from Biology Open after the authors “were unable to repeat the results.” The journal was unable to get in touch with first author Livana Soetedio, whom the University of Illinois at Chicago found had fabricated the data and images in both publications.
Here’s the notice for “Targeting of vasoactive intestinal peptide receptor 2, VPAC2, a secretin family G-protein coupled receptor, to primary cilia”: Continue reading Second retraction appears for arcade game-like image manipulation
A paper by a former postdoc at MD Anderson Cancer Center who “admitted to knowingly and intentionally falsifying” a figure has been retracted.
In August, the Office of Research Integrity announced that it had sanctioned Jun Fu for faking data in a study of the results of a mouse study of NVP-HSP990, a Novartis compound designed to fight brain tumors. Here’s the notice for the study in question, published in Cancer Research:
Continue reading Retraction appears for faked study of Novartis anti-cancer compound
A second retraction has been issued in a case of research misconduct at the chemistry department of chemical engineering at the University of Utah.
The first retraction, in August of 2013, got a lot of attention for how poorly faked the figures were. At the time, an expression of concern was issued on the paper that has just been retracted.
Today, we exchanged emails with Jeffery Botkin, the research integrity officer at the University of Utah, who ran the investigation into the misconduct. He summarized the report for us below. Continue reading University of Utah investigation fingers chem engineering grad student for misconduct
Cardiovascular Research has retracted a 2010 paper by a group of prominent cardiology researchers in Brazil.
The reason: Image manipulation — which the authors say didn’t materially affect the conclusions of the paper.
The article, “FAK mediates the activation of cardiac fibroblasts induced by mechanical stress through regulation of the mTOR complex,” came from a group led by Ana Paula Dalla Costa, from the State University of Campinas.
Here’s the abstract of the study, which has been cited 19 times, according to Thomson Scientific’s Web of Knowledge: Continue reading Heart journal pulls paper for image manipulation
Kidney International is in the process of retracting a stem cell paper containing plagiarized images, Retraction Watch has learned.
Here’s the notice that will appear for “Human renal stem/progenitor cells repair tubular epithelial cell injury through TLR2-driven inhibin-A and microvesicle-shuttled decorin“: Continue reading Kidney journal to retract stem cell paper for duplicated and doctored images
Former University of Tokyo researcher Shigeaki Kato has notched his 26th, 27th, and 28th retractions, all in Nature Cell Biology. The three papers have been cited a total of 677 times.
Here’s the notice for “DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs:” Continue reading Shigeaki Kato up to 28 retractions, with three papers cited nearly 700 times
The former director of the X-ray crystallography lab at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health, faked findings in three papers, according to the Office of Research Integrity.
Two of the three papers by Bijan Ahvazi were published in 2004, and later retracted in 2007, while the other was rejected: Continue reading Former NIH lab director faked findings in three papers: ORI
Molecular Vision has issued “full retractions” for a trio of articles by a group of eye researchers. All of the articles were led by Azza El-Remessy, director of the University of Georgia College of Pharmacy’s clinical and therapeutic graduate program.
As much as that is, there might be more still with this case.
The first paper, from 2000, was titled “Regulation of interphotoreceptor retinoid-binding protein (IRBP) gene expression by cAMP in differentiated retinoblastoma cell.” Its abstract states: Continue reading Molecular Vision retracts three papers from University of Georgia group with error-ridden images
